| CO | Cardiac output |
| con | Control |
| E/é | Early mitral inflow velocity/early diastolic mitral annular velocity |
| Ela | Elamipretide |
| FAC | Fractional area change |
| GLP-1 RA | Glucagon-like peptide-1 receptor agonist |
| HFpEF | Heart failure with preserved ejection fraction |
| HFrEF | Heart failure with reduced ejection fraction |
| LV | Left ventricle |
| LVEDP | Left ventricular end-diastolic pressure |
| LVEDV | Left ventricular end-diastolic volume |
| LVEF | Left ventricular ejection fraction |
| LVESP | Left ventricular end-diastolic pressure |
| LVFS | Left ventricular fractional shortening |
| LVID;d | End-diastolic left ventricular inner diameter |
| LVPW;d | End-diastolic left ventricular posterior wall |
| LVSV | Left ventricular stroke volume |
| MAP | Mean arterial pressure |
| SGLT2i | Sodium–glucose cotransporter 2 inhibitor |
| slope LV-Ees | Slope of left ventricular end-systolic elastance |
| SW | Stroke work |
| Tau | Time constant of left ventricular relaxation |
| TL | Tibia length |
| ZSF1 | Zucker fatty/spontaneously hypertensive heart failure F1 hybrid |